The U.S. Food and Drug Administration has approved tirzepatide for the treatment of moderate-to-severe sleep apnea in adults with obesity.
PHARMACOLOGY UPDATE
Tirzepatide Injection (Zepbound) for Obstructive Sleep Apnea
January 30, 2025
Tirzepatide Injection (Zepbound) for Obstructive Sleep Apnea
January 30, 2025
The U.S. Food and Drug Administration has approved tirzepatide for the treatment of moderate-to-severe sleep apnea in adults with obesity.